Lilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue Guidance by $3 Billion
Go back to Lilly Reports Q2 2024 Financial Results, Raises Full-Year Revenue Guidance by $3 Billion| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1152.93 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1152.93 | 52 Week High | $88.16 | |||
| Open | $1152.93 | 52 Week Low | $67.88 | |||
| Day High | $1152.93 | P/E | 266.88 | |||
| Day Low | $1152.93 | EPS | $4.32 | |||
| Volume | 5,587 | |||||

